메뉴 건너뛰기




Volumn 5, Issue 8, 2015, Pages 1-11

Tuberculosis drug development: History and evolution of the mechanism-based paradigm

Author keywords

[No Author keywords available]

Indexed keywords

BEDAQUILINE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; QUINOLINE DERIVATIVE; TUBERCULOSTATIC AGENT;

EID: 84938690697     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a021147     Document Type: Article
Times cited : (70)

References (93)
  • 5
    • 79960062811 scopus 로고    scopus 로고
    • Lessons from seven decades of antituberculosis drug discovery
    • Barry CE. 2011. Lessons from seven decades of antituberculosis drug discovery. Curr Top Med Chem 11: 1216–1225.
    • (2011) Curr Top Med Chem , vol.11 , pp. 1216-1225
    • Barry, C.E.1
  • 6
    • 0029908204 scopus 로고    scopus 로고
    • The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol
    • Belanger AE, Besra GS, Ford ME, Mikusova K, Belisle JT, Brennan PJ, Inamine JM. 1996. The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc Natl Acad Sci 93: 11919–11924.
    • (1996) Proc Natl Acad Sci , vol.93 , pp. 11919-11924
    • Belanger, A.E.1    Besra, G.S.2    Ford, M.E.3    Mikusova, K.4    Belisle, J.T.5    Brennan, P.J.6    Inamine, J.M.7
  • 7
    • 0029943128 scopus 로고    scopus 로고
    • Molecular mechanisms of drug resistance in Mycobacterium tuberculosis
    • Blanchard JS. 1996. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis. Annu Rev Biochem 65: 215–239.
    • (1996) Annu Rev Biochem , vol.65 , pp. 215-239
    • Blanchard, J.S.1
  • 8
    • 79955855454 scopus 로고
    • Relationship of pyridoxine and its derivatives to the mechanism of action of isoniazid
    • Boone IU, Woodward KT. 1953. Relationship of pyridoxine and its derivatives to the mechanism of action of isoniazid. Proc Soc Exp Biol Med 84: 292–296.
    • (1953) Proc Soc Exp Biol Med , vol.84 , pp. 292-296
    • Boone, I.U.1    Woodward, K.T.2
  • 9
    • 0033797547 scopus 로고    scopus 로고
    • Expression of Mycobacterium smegmatis pyrazinamidase in Mycobacterium tuberculosis confers hypersensitivity to pyrazinamide and related amides
    • Boshoff HI, Mizrahi V. 2000. Expression of Mycobacterium smegmatis pyrazinamidase in Mycobacterium tuberculosis confers hypersensitivity to pyrazinamide and related amides. J Bacteriol 182: 5479–5485.
    • (2000) J Bacteriol , vol.182 , pp. 5479-5485
    • Boshoff, H.I.1    Mizrahi, V.2
  • 10
    • 84871927537 scopus 로고    scopus 로고
    • Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis
    • Chakraborty S, Gruber T, Barry CE III, Boshoff HI, Rhee KY. 2013. Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis. Science 339: 88–91.
    • (2013) Science , vol.339 , pp. 88-91
    • Chakraborty, S.1    Gruber, T.2    Barry, C.3    Boshoff, H.I.4    Rhee, K.Y.5
  • 11
    • 0001019102 scopus 로고
    • Action de l’amide nicotinique sur les bacilles du genre mycobcaterium
    • Chorine V. 1945. Action de l’amide nicotinique sur les bacilles du genre mycobcaterium. C R Hebd Seances Acad Sci 220: 150–151.
    • (1945) C R Hebd Seances Acad Sci , vol.220 , pp. 150-151
    • Chorine, V.1
  • 12
    • 84872131305 scopus 로고    scopus 로고
    • Infectious disease. Approval of novel TB drug celebrated—With restraint
    • Cohen J. 2013. Infectious disease. Approval of novel TB drug celebrated—With restraint. Science 339: 130.
    • (2013) Science , vol.339 , pp. 130
    • Cohen, J.1
  • 13
    • 0018770510 scopus 로고
    • Isoniazid inhibition of the synthesis of monounsaturated long-chain fatty acids in Mycobacterium tuberculosis H37Ra
    • Davidson LA, Takayama K. 1979. Isoniazid inhibition of the synthesis of monounsaturated long-chain fatty acids in Mycobacterium tuberculosis H37Ra. Antimicrob Agents Chemother 16: 104–105.
    • (1979) Antimicrob Agents Chemother , vol.16 , pp. 104-105
    • Davidson, L.A.1    Takayama, K.2
  • 14
    • 78049411009 scopus 로고    scopus 로고
    • Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates
    • de Carvalho LP, Fischer SM, Marrero J, Nathan C, Ehrt S, Rhee KY. 2010. Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates. Chem Biol 17: 1122–1131.
    • (2010) Chem Biol , vol.17 , pp. 1122-1131
    • De Carvalho, L.P.1    Fischer, S.M.2    Marrero, J.3    Nathan, C.4    Ehrt, S.5    Rhee, K.Y.6
  • 15
    • 80955132757 scopus 로고    scopus 로고
    • Nitazoxanide disrupts membrane potential and intrabacterial pH homeostasis of Mycobacterium tuberculosis
    • de Carvalho LP, Darby CM, Rhee KY, Nathan C. 2011. Nitazoxanide disrupts membrane potential and intrabacterial pH homeostasis of Mycobacterium tuberculosis. ACS Med Chem Lett 2: 849–854.
    • (2011) ACS Med Chem Lett , vol.2 , pp. 849-854
    • De Carvalho, L.P.1    Darby, C.M.2    Rhee, K.Y.3    Nathan, C.4
  • 16
    • 0028988237 scopus 로고
    • Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis
    • Dessen A, Quemard A, Blanchard JS, Jacobs WR Jr, Sacchettini JC. 1995. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science 267: 1638–1641.
    • (1995) Science , vol.267 , pp. 1638-1641
    • Dessen, A.1    Quemard, A.2    Blanchard, J.S.3    Jacobs, W.R.4    Sacchettini, J.C.5
  • 17
    • 0014528345 scopus 로고
    • Absorption, metabolism and excretion of pyrazinamide in man
    • Ellard GA. 1969. Absorption, metabolism and excretion of pyrazinamide in man. Tubercle 50: 144–158.
    • (1969) Tubercle , vol.50 , pp. 144-158
    • Ellard, G.A.1
  • 19
    • 0003190187 scopus 로고
    • Effect of ethambutol on nucleic acid metabolism in Mycobacterium smegmatis and its reversal by polyamines and divalent cations
    • Forbes M, Kuck NA, Peets EA. 1965. Effect of ethambutol on nucleic acid metabolism in Mycobacterium smegmatis and its reversal by polyamines and divalent cations. J Bacteriol 89: 1299–1305.
    • (1965) J Bacteriol , vol.89 , pp. 1299-1305
    • Forbes, M.1    Kuck, N.A.2    Peets, E.A.3
  • 20
    • 0001352336 scopus 로고
    • The chemical approach to the control of tuberculosis
    • Fox HH. 1952. The chemical approach to the control of tuberculosis. Science 116: 129–134.
    • (1952) Science , vol.116 , pp. 129-134
    • Fox, H.H.1
  • 21
    • 70349342842 scopus 로고    scopus 로고
    • The arabinosyltransferase EmbC is inhibited by ethambutol in Mycobacterium tuberculosis
    • Goude R, Amin AG, Chatterjee D, Parish T. 2009. The arabinosyltransferase EmbC is inhibited by ethambutol in Mycobacterium tuberculosis. Antimicrob Agents Chemother 53: 4138–4146.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 4138-4146
    • Goude, R.1    Amin, A.G.2    Chatterjee, D.3    Parish, T.4
  • 22
    • 84876070071 scopus 로고    scopus 로고
    • Association between embB mutations and ethambutol resistance in Mycobacterium tuberculosis isolates from Cuba and the Dominican Republic: Reproducible patterns and problems
    • Guerrero E, Lemus D, Yzquierdo S, Vilchez G, Munoz M, Montoro E, Takiff H. 2013. Association between embB mutations and ethambutol resistance in Mycobacterium tuberculosis isolates from Cuba and the Dominican Republic: Reproducible patterns and problems. Rev Argent Microbiol 45: 21–26.
    • (2013) Rev Argent Microbiol , vol.45 , pp. 21-26
    • Guerrero, E.1    Lemus, D.2    Yzquierdo, S.3    Vilchez, G.4    Munoz, M.5    Montoro, E.6    Takiff, H.7
  • 24
    • 35848948213 scopus 로고    scopus 로고
    • In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor
    • Huitric E, Verhasselt P, Andries K, Hoffner SE. 2007. In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor. Antimicrob Agents Chemother 51: 4202–4204.
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 4202-4204
    • Huitric, E.1    Verhasselt, P.2    Ries, K.3    Hoffner, S.E.4
  • 25
    • 77149123917 scopus 로고    scopus 로고
    • Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor
    • Huitric E, Verhasselt P, Koul A, Andries K, Hoffner S, Andersson DI. 2010. Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor. Antimicrob Agents Chemother 54: 1022–1028.
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 1022-1028
    • Huitric, E.1    Verhasselt, P.2    Koul, A.3    Ries, K.4    Hoffner, S.5    Ersson, D.I.6
  • 27
    • 0027993499 scopus 로고
    • Mechanistic studies of the oxidation of isoniazid by the catalase-peroxidase from Mycobacterium tuberculosis
    • Johnsson K, Schultz PG. 1994. Mechanistic studies of the oxidation of isoniazid by the catalase-peroxidase from Mycobacterium tuberculosis. J Am Chem Soc 116: 7425– 7426.
    • (1994) J am Chem Soc , vol.116
    • Johnsson, K.1    Schultz, P.G.2
  • 29
    • 34547500013 scopus 로고
    • The influence of isoniazid and streptomycin on acid-fastness, tetrazolium reduction, growth, and survival of tubercle bacilli
    • Koch-Weser D, Barclay WR, Ebert RH. 1955. The influence of isoniazid and streptomycin on acid-fastness, tetrazolium reduction, growth, and survival of tubercle bacilli. Am Rev Tuberc 71: 556–565.
    • (1955) Am Rev Tuberc , vol.71 , pp. 556-565
    • Koch-Weser, D.1    Barclay, W.R.2    Ebert, R.H.3
  • 30
    • 0014062867 scopus 로고
    • Pyrazinamide susceptibility and amidase activity of tubercle bacilli
    • Konno K, Feldmann FM, McDermott W. 1967. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am Rev Respir Dis 95: 461–469.
    • (1967) Am Rev Respir Dis , vol.95 , pp. 461-469
    • Konno, K.1    Feldmann, F.M.2    McDermott, W.3
  • 33
    • 33845567402 scopus 로고
    • Mode of action of ethambutol on Mycobacterium tuberculosis, strain H37R V
    • Kuck NA, Peets EA, Forbes M. 1963. Mode of action of ethambutol on Mycobacterium tuberculosis, strain H37R V. Am Rev Respir Dis 87: 905–906.
    • (1963) Am Rev Respir Dis , vol.87 , pp. 905-906
    • Kuck, N.A.1    Peets, E.A.2    Forbes, M.3
  • 34
    • 0034723345 scopus 로고    scopus 로고
    • Action mechanism of antitubercular isoniazid. Activation by Mycobacterium tuberculosis KatG, isolation, and characterization of inha inhibitor
    • Lei B, Wei CJ, Tu SC. 2000. Action mechanism of antitubercular isoniazid. Activation by Mycobacterium tuberculosis KatG, isolation, and characterization of inha inhibitor. J Biol Chem 275: 2520–2526.
    • (2000) J Biol Chem , vol.275 , pp. 2520-2526
    • Lei, B.1    Wei, C.J.2    Tu, S.C.3
  • 35
    • 0027262433 scopus 로고
    • Mycobacterium smegmatis RNA polymerase: DNA supercoiling, action of rifampicin and mechanism of rifampicin resistance
    • Levin ME, Hatfull GF. 1993. Mycobacterium smegmatis RNA polymerase: DNA supercoiling, action of rifampicin and mechanism of rifampicin resistance. Mol Microbiol 8: 277–285.
    • (1993) Mol Microbiol , vol.8 , pp. 277-285
    • Levin, M.E.1    Hatfull, G.F.2
  • 38
    • 0029153735 scopus 로고
    • Purification and characterization of the Mycobacterium smegmatis catalase-peroxidase involved in isoniazid activation
    • Marcinkeviciene JA, Magliozzo RS, Blanchard JS. 1995. Purification and characterization of the Mycobacterium smegmatis catalase-peroxidase involved in isoniazid activation. J Biol Chem 270: 22290–22295.
    • (1995) J Biol Chem , vol.270 , pp. 22290-22295
    • Marcinkeviciene, J.A.1    Magliozzo, R.S.2    Blanchard, J.S.3
  • 39
    • 0033962136 scopus 로고    scopus 로고
    • InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II
    • Marrakchi H, Laneelle G, Quemard A. 2000. InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. Microbiology 146: 289–296.
    • (2000) Microbiology , vol.146 , pp. 289-296
    • Marrakchi, H.1    Laneelle, G.2    Quemard, A.3
  • 41
    • 77049188261 scopus 로고
    • Activation of pyrazinamide and nicotinamide in acidic environments in vitro
    • McDermott W, Tompsett R. 1954. Activation of pyrazinamide and nicotinamide in acidic environments in vitro. Am Rev Tuberc 70: 748–754.
    • (1954) Am Rev Tuberc , vol.70 , pp. 748-754
    • McDermott, W.1    Tompsett, R.2
  • 42
    • 0025815311 scopus 로고
    • Location of the mycolyl ester substituents in the cell walls of mycobacteria
    • McNeil M, Daffe M, Brennan PJ. 1991. Location of the mycolyl ester substituents in the cell walls of mycobacteria. J Biol Chem 266: 13217–13223.
    • (1991) J Biol Chem , vol.266 , pp. 13217-13223
    • McNeil, M.1    Daffe, M.2    Brennan, P.J.3
  • 43
    • 84960994147 scopus 로고
    • Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report
    • Middlebrook G. 1954. Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report. Am Rev Tuberc 69: 471–472.
    • (1954) Am Rev Tuberc , vol.69 , pp. 471-472
    • Middlebrook, G.1
  • 45
    • 7244245763 scopus 로고    scopus 로고
    • Antibiotics at the crossroads
    • Nathan C. 2004. Antibiotics at the crossroads. Nature 431: 899–902.
    • (2004) Nature , vol.431 , pp. 899-902
    • Nathan, C.1
  • 46
    • 61849182514 scopus 로고    scopus 로고
    • Taming tuberculosis: A challenge for science and society
    • Nathan C. 2009. Taming tuberculosis: A challenge for science and society. Cell Host Microbe 5: 220–224.
    • (2009) Cell Host Microbe , vol.5 , pp. 220-224
    • Nathan, C.1
  • 48
    • 0035984784 scopus 로고    scopus 로고
    • Mn(III) pyrophosphate as an efficient tool for studying the mode of action of isoniazid on the InhA protein of Mycobacterium tuberculosis
    • Nguyen M, Quemard A, Broussy S, Bernadou J, Meunier B. 2002. Mn(III) pyrophosphate as an efficient tool for studying the mode of action of isoniazid on the InhA protein of Mycobacterium tuberculosis. Antimicrob Agents Chemother 46: 2137–2144.
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 2137-2144
    • Nguyen, M.1    Quemard, A.2    Broussy, S.3    Bernadou, J.4    Meunier, B.5
  • 49
    • 84858790233 scopus 로고    scopus 로고
    • Innovation: Metabolomics: The apogee of the omics trilogy
    • Patti GJ, Yanes O, Siuzdak G. 2012. Innovation: Metabolomics: The apogee of the omics trilogy. Nat Rev Mol Cell Biol 13: 263–269.
    • (2012) Nat Rev Mol Cell Biol , vol.13 , pp. 263-269
    • Patti, G.J.1    Yanes, O.2    Siuzdak, G.3
  • 50
    • 33845903833 scopus 로고    scopus 로고
    • Drugs for bad bugs: Confronting the challenges of antibacterial discovery
    • Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. 2007. Drugs for bad bugs: Confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6: 29–40.
    • (2007) Nat Rev Drug Discov , vol.6 , pp. 29-40
    • Payne, D.J.1    Gwynn, M.N.2    Holmes, D.J.3    Pompliano, D.L.4
  • 52
    • 0039832721 scopus 로고
    • Antagonism of isoniazid by certain metabolites
    • Pope H. 1953. Antagonism of isoniazid by certain metabolites. Am Rev Tuberc 68: 938–939.
    • (1953) Am Rev Tuberc , vol.68 , pp. 938-939
    • Pope, H.1
  • 53
    • 35348818394 scopus 로고
    • The neutralization of isoniazid activity in Mycobacterium tuberculosis by certain metabolites
    • Pope H. 1956. The neutralization of isoniazid activity in Mycobacterium tuberculosis by certain metabolites. Am Rev Tuberc 73: 735–747.
    • (1956) Am Rev Tuberc , vol.73 , pp. 735-747
    • Pope, H.1
  • 55
    • 50149113470 scopus 로고    scopus 로고
    • The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis
    • Rao SP, Alonso S, Rand L, Dick T, Pethe K. 2008. The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proc Natl Acad Sci 105: 11945– 11950.
    • (2008) Proc Natl Acad Sci , vol.105
    • Rao, S.P.1    Alonso, S.2    Rand, L.3    Dick, T.4    Pethe, K.5
  • 57
    • 0345133299 scopus 로고    scopus 로고
    • The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: Adduct affinity and drug resistance
    • Rawat R, Whitty A, Tonge PJ. 2003. The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: Adduct affinity and drug resistance. Proc Natl Acad Sci 100: 13881– 13886.
    • (2003) Proc Natl Acad Sci , vol.100
    • Rawat, R.1    Whitty, A.2    Tonge, P.J.3
  • 58
    • 0032472224 scopus 로고    scopus 로고
    • Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis
    • Rozwarski DA, Grant GA, Barton DH, Jacobs WR Jr, Sacchettini JC. 1998. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 279: 98–102.
    • (1998) Science , vol.279 , pp. 98-102
    • Rozwarski, D.A.1    Grant, G.A.2    Barton, D.H.3    Jacobs, W.R.4    Sacchettini, J.C.5
  • 59
    • 77952356637 scopus 로고    scopus 로고
    • Tuberculosis: What we don’t know can, and does, hurt us
    • Russell DG, Barry CE III, Flynn JL. 2010. Tuberculosis: What we don’t know can, and does, hurt us. Science 328: 852– 856.
    • (2010) Science , vol.328
    • Russell, D.G.1    Barry, C.2    Flynn, J.L.3
  • 60
    • 44449139430 scopus 로고    scopus 로고
    • Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin
    • Safi H, Sayers B, Hazbon MH, Alland D. 2008. Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin. Antimicrob Agents Chemother 52: 2027–2034.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 2027-2034
    • Safi, H.1    Sayers, B.2    Hazbon, M.H.3    Alland, D.4
  • 61
    • 84885003827 scopus 로고    scopus 로고
    • Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-b-D-arabinose biosynthetic and utilization pathway genes
    • Safi H, Lingaraju S, Amin A, Kim S, Jones M, Holmes M, McNeil M, Peterson SN, Chatterjee D, Fleischmann R, et al. 2013. Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-b-D-arabinose biosynthetic and utilization pathway genes. Nat Genet 45: 1190–1197.
    • (2013) Nat Genet , vol.45 , pp. 1190-1197
    • Safi, H.1    Lingaraju, S.2    Amin, A.3    Kim, S.4    Jones, M.5    Holmes, M.6    McNeil, M.7    Peterson, S.N.8    Chatterjee, D.9    Fleischmann, R.10
  • 62
    • 13444249851 scopus 로고    scopus 로고
    • Global strategies to integrate the proteome and metabolome
    • Saghatelian A, Cravatt BF. 2005. Global strategies to integrate the proteome and metabolome. Curr Opin Chem Biol 9: 62–68.
    • (2005) Curr Opin Chem Biol , vol.9 , pp. 62-68
    • Saghatelian, A.1    Cravatt, B.F.2
  • 63
    • 0015782531 scopus 로고
    • Transduction of isoniazid susceptibility-resistance and streptomycin resistance in mycobacteria
    • Saroja D, Gopinathan KP. 1973. Transduction of isoniazid susceptibility-resistance and streptomycin resistance in mycobacteria. Antimicrob Agents Chemother 4: 643–645.
    • (1973) Antimicrob Agents Chemother , vol.4 , pp. 643-645
    • Saroja, D.1    Gopinathan, K.P.2
  • 64
    • 0029954860 scopus 로고    scopus 로고
    • Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus
    • Scorpio A, Zhang Y. 1996. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med 2: 662–667.
    • (1996) Nat Med , vol.2 , pp. 662-667
    • Scorpio, A.1    Zhang, Y.2
  • 66
    • 0001331161 scopus 로고
    • History of the development of rifampin
    • Sensi P. 1983. History of the development of rifampin. Rev Infect Dis 5: S402–S406.
    • (1983) Rev Infect Dis , vol.5 , pp. S402-S406
    • Sensi, P.1
  • 68
    • 80052904114 scopus 로고    scopus 로고
    • Characteristics of embB mutations in multidrugresistant Mycobacterium tuberculosis isolates in Henan, China
    • Shi D, Li L, Zhao Y, Jia Q, Li H, Coulter C, Jin Q, Zhu G. 2011a. Characteristics of embB mutations in multidrugresistant Mycobacterium tuberculosis isolates in Henan, China. J Antimicrob Chemother 66: 2240–2247.
    • (2011) J Antimicrob Chemother , vol.66 , pp. 2240-2247
    • Shi, D.1    Li, L.2    Zhao, Y.3    Jia, Q.4    Li, H.5    Coulter, C.6    Jin, Q.7    Zhu, G.8
  • 70
    • 63549144228 scopus 로고    scopus 로고
    • Emb Nucleotide polymorphisms and the role of embB306 mutations in Mycobacterium tuberculosis resistance to ethambutol
    • Srivastava S, Ayyagari A, Dhole TN, Nyati KK, Dwivedi SK. 2009. emb Nucleotide polymorphisms and the role of embB306 mutations in Mycobacterium tuberculosis resistance to ethambutol. Int J Med Microbiol 299: 269–280.
    • (2009) Int J Med Microbiol , vol.299 , pp. 269-280
    • Srivastava, S.1    Ayyagari, A.2    Dhole, T.N.3    Nyati, K.K.4    Dwivedi, S.K.5
  • 71
    • 0024431530 scopus 로고
    • Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis
    • Takayama K, Kilburn JO. 1989. Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemother 33: 1493–1499.
    • (1989) Antimicrob Agents Chemother , vol.33 , pp. 1493-1499
    • Takayama, K.1    Kilburn, J.O.2
  • 72
    • 0015373050 scopus 로고
    • Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis
    • Takayama K, Wang L, David HL. 1972. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2: 29–35.
    • (1972) Antimicrob Agents Chemother , vol.2 , pp. 29-35
    • Takayama, K.1    Wang, L.2    David, H.L.3
  • 73
    • 0016529811 scopus 로고
    • Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis
    • Takayama K, Schnoes HK, Armstrong EL, Boyle RW. 1975. Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis. J Lipid Res 16: 308–317.
    • (1975) J Lipid Res , vol.16 , pp. 308-317
    • Takayama, K.1    Schnoes, H.K.2    Armstrong, E.L.3    Boyle, R.W.4
  • 74
    • 0018748164 scopus 로고
    • Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis
    • Takayama K, Armstrong EL, Kunugi KA, Kilburn JO. 1979. Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis. Antimicrob Agents Chemother 16: 240–242.
    • (1979) Antimicrob Agents Chemother , vol.16 , pp. 240-242
    • Takayama, K.1    Armstrong, E.L.2    Kunugi, K.A.3    Kilburn, J.O.4
  • 78
    • 20944448468 scopus 로고    scopus 로고
    • Microbial metabolomics: Replacing trial-and-error by the unbiased selection and ranking of targets
    • van der Werf MJ, Jellema RH, Hankemeier T. 2005. Microbial metabolomics: Replacing trial-and-error by the unbiased selection and ranking of targets. J Ind Microbiol Biotechnol 32: 234–252.
    • (2005) J Ind Microbiol Biotechnol , vol.32 , pp. 234-252
    • Van Der Werf, M.J.1    Jellema, R.H.2    Hankemeier, T.3
  • 80
    • 35848935866 scopus 로고    scopus 로고
    • The mechanism of isoniazid killing: Clarity through the scope of genetics
    • Vilcheze C, Jacobs WR Jr. 2007. The mechanism of isoniazid killing: Clarity through the scope of genetics. Annu Rev Microbiol 61: 35–50.
    • (2007) Annu Rev Microbiol , vol.61 , pp. 35-50
    • Vilcheze, C.1    Jacobs, W.R.2
  • 82
    • 0015469593 scopus 로고
    • Relationship between the uptake of isoniazid and its action on in vivo mycolic acid synthesis in Mycobacterium tuberculosis
    • Wang L, Takayama K. 1972. Relationship between the uptake of isoniazid and its action on in vivo mycolic acid synthesis in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2: 438–441.
    • (1972) Antimicrob Agents Chemother , vol.2 , pp. 438-441
    • Wang, L.1    Takayama, K.2
  • 83
    • 0015119823 scopus 로고
    • Actions of the rifamycins
    • Wehrli W, Staehelin M. 1971. Actions of the rifamycins. Bacteriol Rev 35: 290–309.
    • (1971) Bacteriol Rev , vol.35 , pp. 290-309
    • Wehrli, W.1    Staehelin, M.2
  • 84
    • 0033520469 scopus 로고    scopus 로고
    • Spontaneous formation of the bioactive form of the tuberculosis drug isoniazid
    • Wilming M, Johnsson K. 1999. Spontaneous formation of the bioactive form of the tuberculosis drug isoniazid. Angew Chem Int Ed Engl 38: 2588–2590.
    • (1999) Angew Chem Int Ed Engl , vol.38 , pp. 2588-2590
    • Wilming, M.1    Johnsson, K.2
  • 85
    • 0001971349 scopus 로고
    • Catalase and peroxidase in mycobacteria. Possible relationship to the mode of action of isoniazid
    • Winder F. 1960. Catalase and peroxidase in mycobacteria. Possible relationship to the mode of action of isoniazid. Am Rev Respir Dis 81: 68–78.
    • (1960) Am Rev Respir Dis , vol.81 , pp. 68-78
    • Winder, F.1
  • 86
    • 0014841450 scopus 로고
    • Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis
    • Winder FG, Collins PB. 1970. Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis. J Gen Microbiol 63: 41–48.
    • (1970) J Gen Microbiol , vol.63 , pp. 41-48
    • Winder, F.G.1    Collins, P.B.2
  • 87
    • 0014776244 scopus 로고
    • Effects of isoniazid on mycolic acid synthesis in Mycobacterium tuberculosis and on its cell envelope
    • Winder FG, Collins P, Rooney SA. 1970. Effects of isoniazid on mycolic acid synthesis in Mycobacterium tuberculosis and on its cell envelope. Biochem J 117: 27P.
    • (1970) Biochem J , vol.117 , pp. 27
    • Winder, F.G.1    Collins, P.2    Rooney, S.A.3
  • 88
    • 13844319812 scopus 로고    scopus 로고
    • The magic bullets and tuberculosis drug targets
    • Zhang Y. 2005. The magic bullets and tuberculosis drug targets. Annu Rev Pharmacol Toxicol 45: 529–564.
    • (2005) Annu Rev Pharmacol Toxicol , vol.45 , pp. 529-564
    • Zhang, Y.1
  • 89
    • 0037252098 scopus 로고    scopus 로고
    • The curious characteristics of pyrazinamide: A review
    • Zhang Y, Mitchison D. 2003. The curious characteristics of pyrazinamide: A review. Int J Tuberc Lung Dis 7: 6–21.
    • (2003) Int J Tuberc Lung Dis , vol.7 , pp. 6-21
    • Zhang, Y.1    Mitchison, D.2
  • 90
    • 0032936728 scopus 로고    scopus 로고
    • Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide
    • Zhang Y, Scorpio A, Nikaido H, Sun Z. 1999. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Bacteriol 181: 2044–2049.
    • (1999) J Bacteriol , vol.181 , pp. 2044-2049
    • Zhang, Y.1    Scorpio, A.2    Nikaido, H.3    Sun, Z.4
  • 91
    • 0242437861 scopus 로고    scopus 로고
    • Mode of action of pyrazinamide: Disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid
    • Zhang Y, Wade MM, Scorpio A, Zhang H, Sun Z. 2003. Mode of action of pyrazinamide: Disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J Antimicrob Chemother 52: 790– 795.
    • (2003) J Antimicrob Chemother , vol.52
    • Zhang, Y.1    Wade, M.M.2    Scorpio, A.3    Zhang, H.4    Sun, Z.5
  • 92
    • 84877267006 scopus 로고    scopus 로고
    • Advances in the development of new tuberculosis drugs and treatment regimens
    • Zumla A, Nahid P, Cole ST. 2013. Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Discov 12: 388–404.
    • (2013) Nat Rev Drug Discov , vol.12 , pp. 388-404
    • Zumla, A.1    Nahid, P.2    Cole, S.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.